11/19/2026 | News release | Distributed by Public on 11/19/2026 08:09
On 4 January 2027 Swissmedic is switching the process for the notification procedure for complementary medicines without indication. In future, single notifications will be recorded and newly applied for via the Swissmedic Portal. In this context, the existing "HOMANT" application will be decommissioned on 31 December 2026.
This switch, which is part of Swissmedic's ongoing digitalisation initiative and the modernisation of the application landscape, will affect all newly submitted single notifications (relating to new and ongoing applications for the new authorisation of complementary medicines under the notification procedure) as well as new authorisations of master dossiers. Companies are asked to take the upcoming changes into account in their planning.
Further information on the new process, the technical requirements and the transitional rulings will be available on our Swissmedic website prior to the switch.